Esketamine Treatment & Depression
Spravato™ Nasal Spray
The FDA has now approved the first drug that can relieve depression in hours instead of weeks. In a recent article titled “FDA Approves Esketamine Nasal Spray For Hard-To-Treat Depression,“ NPR stated:
“There has been a long-standing need for additional effective treatments for treatment-resistant depression, a serious and life-threatening condition,” said Dr. Tiffany Farchione, acting director of the Division of Psychiatry Products in the FDA’s Center for Drug Evaluation and Research, in a press release about the decision.
‘This is potentially a game-changer for millions of people,’ said Dr. Dennis Charney, Dean of the Icahn School of Medicine at Mount Sinai in New York. ‘It offers a lot of hope.’”
Spravato™ (esketamine) Recommended Treatment Protocols / Pricing:
Most insurance companies are now covering Spravato therapy; with a referral, our insurance coordinator can assist with your preauthorization. The recommended Spravato administration is typically twice a week for four weeks and then weekly or every other week thereafter.
“Dr. G is a kind, considerate, professional who listens to her patients. I didn’t feel insecure or like I was just another patient to her. She cares and that’s what matters.”
Julie P.
Client
Your life is important, it’s time to start living it!
“Our team at Pacific Phoenix Psychiatry is here to Help! We have helped hundreds of patients unlock their potential for a better life. We have help thousands boost brain activity in the area of the brain responsible for depression.
Elia Gonzalez-Rodriguez, M.D.
Pacific Phoenix Psychiatry